Cargando…

Staphylococcus aureus : molecular and clinical aspects /

Staphylococcus aureus is resident in skin and nasal membranes with a formidable pathogenic potential to cause a variety of community and hospital acquired infections. This authoritative survey covers the impact of genome sequences into our understanding of MRSA and MSSA pathogenesis. World specialis...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Ala'Aldeen, Dlawer A. A., Hiramatsu, Keiichi, 1949-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Chichester, U.K. : Horwood Pub., 2004.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover; Staphylococcus Aureus: Molecular and Clinical Aspects; Copyright Page; Table of contents; Chapter contributors; Preface; Chapter 1. Staphylococcal Infection: Emerging Clinical Syndromes; 1.1 INTRODUCTION; 1.2 BACTERAEMIA; 1.3 ENDOVASCULAR INFECTION; 1.4 BREAST INFECTIONS; 1.5 CELLULITIS; 1.6 DENTAL; 1.7 DIALYSIS-RELATED INFECTIONS; 1.8 EYE INFECTIONS; 1.9 ENTEROCOLITIS; 1.10 INTRA-ABDOMINAL; 1.11 CENTRAL NERVIOUS SYSTEM; 1.12 MYOCARDITIS/ PERICARDITIS; 1.13 NASAL COLONIZATION; 1.14 OSTEOMYELITIS/DISCITIS/ DIABETIC FOOT; 1.15 PAROTITIS; 1.16 RESPIRATORY INFECTIONS.
  • 1.17 SURGICAL SITE INFECTIONS1.18 SMALL COLONY VARIANTS OF SA; 1.19 TOXIC SHOCK SYNDROME; 1.20 URINARY TRACT INFECTION; 1.21 VASCULAR INFECTIONS; 1.22 CONCLUSION; ACKNOWLEDGMENT; REFERENCES; Chapter 2. Epidemiology of MRSA and MSSA; 2.1 RESERVOIRS; 2.2 THE POPULATION STRUCTURE OF S. AUREUS; 2.3 ROUTES OF TRANSMISSION; 2.4 THE HOST POPULATION; 2.5 CONCLUSIONS; REFERENCES; Chapter 3. The Staphylococcus aureus Genome; 3.1 INTRODUCTION; 3.2 PHYSICAL PROPERTIES OF S. AUREUS GENOME; 3.3 FUNCTIONAL ORGANIZATION OF S. aureus GENOME; 3.4 POLYMORPHISM OF S. AUREUS GENOME AND GENOME ALLOTYPING.
  • 3.5 CONCLUSIONACKNOWLEDGEMENT; REFERENCES; Chapter 4. Virulence Gene Regulation and their role in pathogenesis of disease; 4.1 INTRODUCTION; 4.2 THE ACCESSORY GENE REGULATOR, agr.; 4.3 THE SarA FAMILY OF TRANSCRIPTION FACTORS; 4.4 SIGMA FACTOR B; 4.5 TWO-COMPONENT SIGNAL TRANSDUCTION SYSTEMS; 4.6 ROLE OF VIRULENCE REGULATORS IN INFECTION; REFERENCES; Chapter 5. Pathogenesis of disease; 5.1 INTRODUCTION; 5.2 S. AUREUS ENCAPSULATION; 5.3 BIOFILM FORMATION; 5.4 ADHERENCE; 5.5 COLONIZATION; 5.6 IRON ACQUISITION; 5.7 INTERNALIZATION OF S. AUREUS BY NON-PROFESSIONAL PHAGOCYTES.
  • 5.8 STAPHYLOCOCCAL EXOTOXINSACKNOWLEDGEMENTS; REFERENCES; Chapter 6. Antimicrobial Resistance and Therapy of Staphylococcus aureus Infections; 6.1 BASIC MECHANISMS OF RESISTANCE; 6.2 BETA-LACTAM ANTIBIOTICS; 6.3 GLYCOPEPTIDES; 6.4 MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS; 6.5 LINEZOLID; 6.6 FLUOROQUINOLONES; 6.7 RIFAMPIN; 6.8 MISCELLANEOUS AGENTS; 6.9 THERAPEUTIC CONSIDERATIONS; REFERENCES.